BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 26425429)

  • 1. Nanotechnology in the real world: Redeveloping the nanomaterial consumer products inventory.
    Vance ME; Kuiken T; Vejerano EP; McGinnis SP; Hochella MF; Rejeski D; Hull MS
    Beilstein J Nanotechnol; 2015; 6():1769-80. PubMed ID: 26425429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence in, and release of, nanomaterials from consumer products.
    Yang Y; Westerhoff P
    Adv Exp Med Biol; 2014; 811():1-17. PubMed ID: 24683024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Categorization framework to aid exposure assessment of nanomaterials in consumer products.
    Hansen SF; Michelson ES; Kamper A; Borling P; Stuer-Lauridsen F; Baun A
    Ecotoxicology; 2008 Jul; 17(5):438-47. PubMed ID: 18454314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hierarchy of environmental health and safety practices in the U.S. nanotechnology workplace.
    Engeman CD; Baumgartner L; Carr BM; Fish AM; Meyerhofer JD; Satterfield TA; Holden PA; Harthorn BH
    J Occup Environ Hyg; 2013; 10(9):487-95. PubMed ID: 23927041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure assessment approaches for engineered nanomaterials.
    Abbott LC; Maynard AD
    Risk Anal; 2010 Nov; 30(11):1634-44. PubMed ID: 20626687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive survey of consumer awareness of nanotechnologies and nanoparticles in consumer products in South Korea.
    Kim YR; Lee EJ; Park SH; Kwon HJ; An SS; Son SW; Seo YR; Pie JE; Yoon M; Kim JH; Kim MK
    Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):11-20. PubMed ID: 25565822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of nanomaterials from solid nanocomposites and consumer exposure assessment - a forward-looking review.
    Mackevica A; Foss Hansen S
    Nanotoxicology; 2016 Aug; 10(6):641-53. PubMed ID: 26667577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status and prospects of population exposure assessment of nanomaterials consumer products].
    Zou XX; Zhang B; Liu LH; Wang HJ; Wu JQ; Yang QY; Zhang XJ; Liu ZQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Aug; 54(8):902-907. PubMed ID: 32842322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are environmental regulations keeping up with innovation? A case study of the nanotechnology industry.
    Fairbrother A; Fairbrother JR
    Ecotoxicol Environ Saf; 2009 Jul; 72(5):1327-30. PubMed ID: 19423165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of nanotechnology awareness in consumers and experts in South Korea.
    Kim YR; Lee EJ; Park SH; Kwon HJ; An SS; Son SW; Seo YR; Pie JE; Yoon M; Kim JH; Kim MK
    Int J Nanomedicine; 2014; 9 Suppl 2(Suppl 2):21-7. PubMed ID: 25565823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Getting it right the first time: developing nanotechnology while protecting workers, public health, and the environment.
    Balbus JM; Florini K; Denison RA; Walsh SA
    Ann N Y Acad Sci; 2006 Sep; 1076():331-42. PubMed ID: 17119213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.
    Tyner KM; Zheng N; Choi S; Xu X; Zou P; Jiang W; Guo C; Cruz CN
    AAPS J; 2017 Jul; 19(4):1071-1083. PubMed ID: 28421428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blueprint for a self-sustained European Centre for service provision in safe and sustainable innovation for nanotechnology.
    Marcoulaki E; López de Ipiña JM; Vercauteren S; Bouillard J; Himly M; Lynch I; Witters H; Shandilya N; van Duuren-Stuurman B; Kunz V; Unger WES; Hodoroaba VD; Bard D; Evans G; Jensen KA; Pilou M; Viitanen AK; Bochon A; Duschl A; Geppert M; Persson K; Cotgreave I; Niga P; Gini M; Eleftheriadis K; Scalbi S; Caillard B; Arevalillo A; Frejafon E; Aguerre-Chariol O; Dulio V
    NanoImpact; 2021 Jul; 23():100337. PubMed ID: 35559838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nanomaterial Registry: facilitating the sharing and analysis of data in the diverse nanomaterial community.
    Ostraat ML; Mills KC; Guzan KA; Murry D
    Int J Nanomedicine; 2013; 8 Suppl 1(Suppl 1):7-13. PubMed ID: 24098075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Tools to Support the Risk Assessment Process of Nanomaterials in the Insurance Sector.
    Aznar Mollá F; Fito-López C; Heredia Alvaro JA; Huertas-López F
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34210019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing of Nanoparticle Release from a Composite Containing Nanomaterial Using a Chamber System.
    Lee GH; Ahn KH; Yu IJ
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop.
    Warheit DB; Borm PJ; Hennes C; Lademann J
    Inhal Toxicol; 2007 Jun; 19(8):631-43. PubMed ID: 17510836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Life Cycle of Engineered Nanoparticles.
    González-Gálvez D; Janer G; Vilar G; Vílchez A; Vázquez-Campos S
    Adv Exp Med Biol; 2017; 947():41-69. PubMed ID: 28168665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology in agriculture: Opportunities, toxicological implications, and occupational risks.
    Iavicoli I; Leso V; Beezhold DH; Shvedova AA
    Toxicol Appl Pharmacol; 2017 Aug; 329():96-111. PubMed ID: 28554660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.